Analyst Activity – Needham & Company LLC Initiates Coverage On Biodel (NASDAQ:ALBO) With a Buy

Analyst Ratings For Biodel (NASDAQ:ALBO)

Story continues below

Today, Needham & Company LLC initiated coverage on Biodel (NASDAQ:ALBO) with a Buy with a price target of $35.00.

There are 4 buy ratings on the stock.

The current consensus rating on Biodel (NASDAQ:ALBO) is Buy (Score: 3.00) with a consensus target price of $35.00 per share, a potential 28.06% upside.

Some recent analyst ratings include

  • 7/18/2017-Needham & Company LLC initiated coverage with a Buy rating.
  • 6/30/2017-Wedbush initiated coverage with a Outperform rating.
  • 2/16/2017-Ladenburg Thalmann Financial Services initiated coverage with a Buy rating.
  • 1/25/2017-William Blair initiated coverage with a Outperform rating.

Recent Insider Trading Activity For Biodel (NASDAQ:ALBO)
Biodel (NASDAQ:ALBO) has insider ownership of 22.30% and institutional ownership of 12.35%.

  • On 12/20/2013 Brian Jg Pereira, Director, sold 4,734 with an average share price of $2.26 per share and the total transaction amounting to $10,698.84. View SEC Filing

Recent Trading Activity for Biodel (NASDAQ:ALBO)
Shares of Biodel closed the previous trading session at 27.33 up +0.56 2.09% with 59,124 shares trading hands.

An ad to help with our costs